Skip to main content
. 2017 Aug 10;108(9):1811–1819. doi: 10.1111/cas.13315

Figure 7.

Figure 7

Regulation pathway: miR‐372 inhibits survival of human pancreatic adenocarcinoma (HPAC) cells through regulating autophagy by targeting ULK1.